APVO - Aptevo Therapeutics EPS beats by $0.01 beats on revenue November, 07 2019 09:26 AM Aptevo Therapeutics Inc. Aptevo Therapeutics (NASDAQ:APVO): Q3 GAAP EPS of -$0.23 beats by $0.01.More news on: Aptevo Therapeutics Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...